Transcode Therapeutics Filed U.S. Patent Application # 20240042070: NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY
Transcode Therapeutics Filed U.S. Patent Application # 20240042070: NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY
Transcode Therapeutics 提交了美國專利申請 # 20240042070：納米顆粒和模板定向 RIG-I 激動劑前體組合物及其在癌症治療中的用途
Transcode Therapeutics Filed U.S. Patent Application # 20240042070: NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY
Transcode Therapeutics 提交了美國專利申請 # 20240042070：納米顆粒和模板定向 RIG-I 激動劑前體組合物及其在癌症治療中的用途
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。